cfDNA analysis of maternal blood
- Accurate gender determination using a single-nucleotide polymorphism-based non-invasive prenatal test
- First results of NIPT in France after 18 months of analysis
- Clinical laboratory experience with NIPT: update on clinically relevant metrics
- Maternal cfDNA sequencing vs. standard prenatal aneuploidy screening in a general obstetrical population
- Leveraging NIPT in Ontario to advocate for an improved provincial prenatal screening program
- Clinical implementation of non-invasive prenatal aneuploidy detection
- Women’s uptake of NIPT following a high risk screening test for trisomy 21 within a publicly funded healthcare system
- Micro mRNAs in maternal plasma for NIPT of Down syndrome
- Establishment of a robust approach for blind detection of balanced chromosomal rearrangements by NGS
- Determination of the fetal KEL genotype fromcfDNA in maternal blood
- NIPT: impact in Portuguese pregnant population
- Validation study of NIPT for fetal sex and RhD status determination
- Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing
- NIPT for fetal trisomies in routine first-trimester screening
- Genome wide analysis of sub chromosomal copy number variations using NIPT in over 4500 patients
- cfDNA fetal fraction and relationship to first-trimester uterine artery PI
- Impact of cfDNA testing after 1st trimester combined screening on the rate of invasive procedures
- Validating of NIPT for 22q11.2 deletion using artificial pregnancy plasma samples
- Accurate gender determination using a single nucleotide polymorphism-based NIPT
- SNP-based non-invasive prenatal testing identifies vanishing-twin pregnancies
- Accuracy of NIPT for chromosomal aneuploidies: systematic review of literature
- NIPT for fetal large deletions or duplications by low coverage MPSS
- NIPT for fetal sex determination and application in X-linked disorder counseling
- NIPT for trisomies 21 and 18 by MPSS in twins